BlackRock Fund Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22K	Buy	5,277 +1,061	+25%	+$4.4K	﹤0.01%	3875
2016 Q3	$16K	Sell	4,216 -3,790	-47%	-$13.8K	﹤0.01%	3905
2016 Q2	$27K	Sell	8,006 -596,356	-99%	-$2.74M	﹤0.01%	3885
2016 Q1	$3.21M	Buy	604,362 +27,753	+5%	+$222K	﹤0.01%	2938
2015 Q4	$7.09M	Buy	576,609 +147,586	+34%	+$1.97M	﹤0.01%	2649
2015 Q3	$6.26M	Buy	429,023 +5,029	+1%	+$86.9K	﹤0.01%	2667
2015 Q2	$8.27M	Buy	423,994 +4,224	+1%	+$81.5K	﹤0.01%	2616
2015 Q1	$7.6M	Buy	419,770 +3,376	+0.8%	+$76K	﹤0.01%	2601
2014 Q4	$9.83M	Buy	416,394 +91,123	+28%	+$2.11M	﹤0.01%	2469
2014 Q3	$7.87M	Sell	325,271 -10,288	-3%	-$267K	﹤0.01%	2493
2014 Q2	$9.43M	Sell	335,559 -26,044	-7%	-$783K	﹤0.01%	2457
2014 Q1	$12.3M	Buy	361,603 +13,517	+4%	+$462K	﹤0.01%	2280
2013 Q4	$6.65M	Buy	348,086 +30,549	+10%	+$556K	﹤0.01%	2635
2013 Q3	$5.15M	Buy	317,537 +36,810	+13%	+$427K	﹤0.01%	2798
2013 Q2	$2.95M	Buy	+280,727	New	+$3.29M	﹤0.01%	2998